NCT03019302View on ClinicalTrials.gov

Arrow Chloragard Peripherally-Inserted Central Catheters (PICC) Study

NAUnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

September 30, 2017

Conditions
Vascular Access ComplicationVascular Access Related Infection
Interventions
DEVICE

Arrow PICC with Chloragard Technology

chlorhexidine is chemically bonded to the intra- luminal catheter surfaces from tip to hub, and extra-luminal catheter body

Trial Locations (2)

40506

RECRUITING

University of Kentucky Medical Center, Lexington

48201

RECRUITING

Detroit Medical Center, Detroit

Sponsors

Collaborators (1)

Arrow International
All Listed Sponsors
collaborator

Arrow International

INDUSTRY

lead

Teleflex

INDUSTRY

NCT03019302 - Arrow Chloragard Peripherally-Inserted Central Catheters (PICC) Study | Biotech Hunter | Biotech Hunter